UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000055785 |
|---|---|
| Receipt number | R000063742 |
| Scientific Title | Evaluation of the effects of foods containing olive leaf extract powder for skin |
| Date of disclosure of the study information | 2024/10/08 |
| Last modified on | 2024/10/21 13:42:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the effects of foods containing olive leaf extract powder for skin
Acronym
Evaluation of the effects of foods containing olive leaf extract powder for skin
Scientific Title
Evaluation of the effects of foods containing olive leaf extract powder for skin
Scientific Title:Acronym
Evaluation of the effects of foods containing olive leaf extract powder for skin
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To verify the effects on skin based on skin texture, wrinkles, brightness, the age of skin, and blood vessel age after consumption for 12 weeks of olive leaf extract powder.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
VISIA score
Key secondary outcomes
(1) Transedermal water loss (TEWL)
(2) Water content
(3) Blood vessel age
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Daily intake of test food for 12 weeks
Interventions/Control_2
Daily intake of placebo (control food) for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| 69 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Healthy Japanese men and women between the ages of 40 and 69 at the time of consent.
2) Persons who feel that their skin is aging but are not taking active anti-aging care.
3) Persons who have been fully informed of the purpose and content of the study, and submit the written informed consent form
Key exclusion criteria
1)Persons who are on treatment for a serious illness.
2) Persons with or treating skin disease.
3) Persons who can be expected to have hay fever during the study.
4) Persons who had procedures that may affect the study.
5) Persons with food allergies or those who may be allergic to the test food.
6) Persons who regularly use licensed drugs or quasi-drugs that may affect the study.
7) Persons who regularly use health foods that may affect the study.
8) Persons who are participating in a clinical trial or have participated in another clinical trial within 1 months from the date of obtaining consent.
9) Persons with excessive sunburn.
10) Persons who intentionally cannot refrain from exposure to direct sunlight during the study.
11) Persons who are smokers or who are currently nonsmokers but have smoked within 3 months prior to the start of the study.
12) Persons who receive skin care treatments or use beauty devices daily.
13) Persons who have experience in cosmetic surgery.
14) Persons who have tattoos, surgical scars, or other scars on the measurement area (face or forearms)
15) Persons unable to maintain daily routines.
16) Persons who are on pregnant, lactating, or wishing to become pregnant.
17) Persons who plan to participate in other examinations during the study.
18) Persons who are deemed inappropriate for this study by the investigator.
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Marie |
| Middle name | |
| Last name | Hayashida |
Organization
Nutrition Act Co.,Ltd.
Division name
Planning Sect
Zip code
104-0061
Address
3F Office floor, Daiwa Royal Ginza Bldg. 1-13-15 Ginza, Chuo-ku, Tokyo 104-0061 JAPAN
TEL
03-3538-5811
m-hayashida@n-act.co.jp
Public contact
Name of contact person
| 1st name | Masako |
| Middle name | |
| Last name | Mizuuchi |
Organization
APO PLUS STATION CO., LTD.
Division name
Clinical Operations Dept., CRO Business div.
Zip code
103-0027
Address
2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan
TEL
03-6777-7789
Homepage URL
food-contact@apoplus.co.jp
Sponsor or person
Institute
APO PLUS STATION CO., LTD.
Institute
Department
Personal name
Funding Source
Organization
Nutrition Act Co.,Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Review Committee of Watanabe Hospital
Address
1-5-16, Haneda, Otaku, Tokyo, 144-0043, Japan
Tel
03-3741-0223
food-contact@apoplus.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
医療法人社団 渡辺病院(東京都）
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 10 | Month | 08 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2024 | Year | 10 | Month | 04 | Day |
Date of IRB
| 2003 | Year | 10 | Month | 08 | Day |
Anticipated trial start date
| 2024 | Year | 10 | Month | 09 | Day |
Last follow-up date
| 2025 | Year | 02 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2024 | Year | 10 | Month | 08 | Day |
Last modified on
| 2024 | Year | 10 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063742
